Cargando…
Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS
BACKGROUND: We tested the hypothesis that moxifloxacin monotherapy is equally effective and safe as a betalactam antibiotic based combination therapy in patients with acute respiratory distress syndrome (ARDS) evoked by severe community acquired pneumonia (CAP). METHODS: In a retrospective chart rev...
Autores principales: | Rahmel, Tim, Asmussen, Sven, Karlik, Jan, Steinmann, Jörg, Adamzik, Michael, Peters, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471686/ https://www.ncbi.nlm.nih.gov/pubmed/28615012 http://dx.doi.org/10.1186/s12871-017-0376-5 |
Ejemplares similares
-
The aquaporin 5 -1364A/C promoter polymorphism impacts on resolution of acute kidney injury in pneumonia evoked ARDS
por: Rahmel, Tim, et al.
Publicado: (2018) -
Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020) -
A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP)
por: Ferrara, Anna M
Publicado: (2007) -
Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002) -
Moxifloxacin Monotherapy in Left-Sided Staphylococcus aureus Endocarditis
por: Colkesen, Yucel
Publicado: (2021)